patient_id,criteria,meets_criterion,justification
11469267,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
19706200,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Aripiprazole (15mg Tab) from 2135-10-07 to 2135-10-08 (1 day) and Haloperidol (5 mg Tab) from 2135-10-10 to 2135-10-13 (3 days), neither of which meets the 4-week (28 days) stable dosing requirement."
19700168,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Aripiprazole (10 mg Tablet) from 2152-04-29 to 2152-05-01 (2 days), Quetiapine Fumarate (200mg Tablet) from 2148-01-15 to 2148-01-26 (11 days), and Haloperidol (5 mg Tab) from 2148-01-02 to 2148-01-10 (8 days). None of these antipsychotics were administered for a duration of 28 days or more."
10884708,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed RisperiDONE 0.5mg Tablet from 2170-08-22 to 2170-08-26 (4 days) and Prochlorperazine 10 mg Tab on 2171-10-13 (no stop date provided), neither of which meets the 4-week stable dosing requirement."
10154654,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient is prescribed RisperiDONE (0.5mg Tablet and 2mg Tablet) and Latuda (40 mg Tablet). For RisperiDONE 0.5mg Tablet, the start date is 2121-05-07 12:00:00 and stop date is 2121-05-09 18:00:00 (duration 2 days). For RisperiDONE 2mg Tablet, the start date is 2121-05-07 22:00:00 and stop date is 2121-05-07 11:00:00 (invalid duration). For Latuda, the start date is 2121-05-07 22:00:00 and stop date is 2121-05-09 18:00:00 (duration 1 day). None of these meet the 4-week requirement."
15112182,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient is prescribed QUEtiapine extended-release (300 mg XR tablet) from 2133-07-18 22:00:00 to 2133-07-29 18:00:00 (11 days) and QUEtiapine Fumarate (25mg Tablet) from 2133-07-19 16:00:00 to 2133-07-29 18:00:00 (10 days), neither of which meets the 4-week (28 days) stable dosing requirement. No other antipsychotics with sufficient duration are recorded."
18403514,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
16548967,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Risperidone (2mg Tablet) from 2179-04-05 22:00:00 to 2179-04-06 18:00:00 and again from 2186-07-17 22:00:00 to 2186-07-20 20:00:00, with a continuous duration of 3 days, which does not meet the 4-week requirement; however, the patient was also prescribed RisperiDONE (0.5mg Tablet) from 2186-10-02 22:00:00 to 2186-10-05 01:00:00 and RisperiDONE (1mg Tablet) from 2186-10-02 22:00:00 to 2186-10-05 01:00:00, with a continuous duration of 3 days, which also does not meet the requirement; but the patient was on RisperiDONE (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, and RisperiDONE (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which still does not meet the 4-week requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (2mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; however, the patient was on Risperidone (1mg Tablet) from 2187-05-21 20:00:00 to 2187-06-07 19:00:00, a continuous duration of 17 days, which does not meet the requirement; but the patient was on Risperidone (0.5mg Tablet) from 2187"
11812528,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"The patient's records do not contain any information about prescribed antipsychotic medications, including medication names, dosages, start dates, or stop dates, which are necessary to evaluate the stable dosing duration."
18581630,4. Stable dose of antipsychotic for at least 4 weeks.,No,"The patient is prescribed Clozapine (100mg Tablet) with a recorded start date of 2166-03-20 22:00:00 and stop date of 2166-03-24 00:00:00, resulting in a duration of approximately 3 days, which is less than the required 4 weeks. No other antipsychotics were found in the records."
18709925,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Quetiapine extended-release (200 mg XR Tablet) for 1 day (2174-09-09 to 2174-09-09), Haloperidol (5mg/mL Vial) for 3 days (2177-05-14 to 2177-05-16), and Risperidone (1mg Tablet) for 3 days (2178-05-30 to 2178-06-01). None of these durations meet the 4-week requirement."
11197450,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed multiple antipsychotics: Haloperidol (5 mg Tab from 2133-01-22 to 2133-01-29, 7 days; 10 mg Tab from 2133-01-29 to 2133-02-05, 7 days), ARIPiprazole (10 mg Tablet from 2133-02-09 to 2133-02-12, 3 days), OLANZapine (10mg Vial from 2133-02-22 to 2133-03-11, 17 days), and PALIperidone Palmitate (156 mg Syringe on 2133-04-11, single day). None of these medications were administered for a continuous duration of 28 days or more."
13909531,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed RisperiDONE (1mg and 0.5mg tablets) from 2115-03-06 to 2115-03-14 (8 days), PALIperidone ER (3 mg and 6 mg ER tablets) from 2117-03-22 to 2117-04-01 (10 days), and ARIPiprazole (10 mg tablet) from 2117-03-12 to 2117-03-14 (2 days), none of which meet the 28-day requirement."
16093686,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications are listed in the patient's records; only medications like Omeprazole, Influenza Virus Vaccine, Diazepam, and others are mentioned, none of which are antipsychotics."
17277265,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Haloperidol (5 mg Tab) from 2172-12-14 to 2172-12-18 (4 days), Haloperidol (5mg/mL Vial) from 2173-07-28 to 2173-10-19 (83 days), Haloperidol (Conc: 2mg/mL Oral Liquid) from 2173-08-05 to 2173-08-17 (12 days), Haloperidol (5 mg Tab) from 2173-07-28 to 2173-07-31 (3 days), Haloperidol Decanoate (long acting, 100 mg / mL Vial) from 2173-09-23 to 2173-10-26 (33 days), and OLANZapine (5mg Tablet) from 2173-09-03 to 2173-10-26 (53 days). The durations for Haloperidol (5mg/mL Vial), Haloperidol Decanoate, and OLANZapine each exceed 28 days."
18988288,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Quetiapine Fumarate (25mg Tablet) from 2115-03-07 to 2115-03-11 (4 days), Quetiapine Fumarate (100mg Tablet) from 2115-03-18 to 2115-03-19 (1 day), Risperidone (1mg Tablet) from 2115-03-11 to 2115-03-19 (8 days), Risperidone (2mg Tablet) from 2115-03-12 to 2115-03-19 (7 days), and Risperidone Long Acting Injection (25mg Injection) from 2115-03-08 to 2115-03-19 (11 days). None of these medications were prescribed for a duration of 28 days or more."
11298819,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient's most recent antipsychotic prescriptions (Perphenazine 8 mg Tab and Quetiapine extended-release 200 mg XR Tablet) had durations of 11 days and 11 days respectively, which do not meet the 4-week stable dosing requirement."
15150123,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Quetiapine Fumarate (50mg and 200mg tablets) and RisperiDONE (2mg tablet). Quetiapine 50mg was administered on 2115-06-28 for 2 hours (16:00 to 21:00), and Quetiapine 200mg was administered on 2115-06-28 for 13 hours (08:00 to 21:00). RisperiDONE was administered on 2122-01-05 for 3 days (21:00 to 20:00). None of these durations meet the 4-week (28 days) requirement."
16191898,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed lurasidone (40 mg Tablet) from 2110-11-03 to 2110-11-05 (2 days), aripiprazole (5 mg Tablet) from 2110-11-03 to 2110-11-09 (6 days), and quetiapine fumarate (25 mg Tablet) from 2110-11-12 to 2110-11-19 (7 days); none of these antipsychotics were administered for a continuous duration of 28 days or more."
13631551,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed multiple antipsychotics: Quetiapine Fumarate (100mg Tablet) from 2134-09-12 to 2134-09-13 (1 day), Risperidone Long Acting Injection (25mg Injection) from 2134-09-26 to 2134-09-30 (4 days), Risperidone (2mg Tablet) from 2134-09-18 to 2134-09-19 (1 day), Risperidone (1mg Tablet) from 2134-09-09 to 2134-09-18 (9 days), and Quetiapine Fumarate (200mg Tablet) from 2134-09-18 to 2134-09-25 (7 days). None of these medications were administered for a continuous period of 28 days or more."
19903733,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5mg/mL Vial) from 2111-10-14 to 2111-10-15 (1 day), Olanzapine (5mg Tablet) from 2111-10-14 to 2111-10-17 (3 days), Olanzapine (7.5mg Tab) from 2111-10-18 to 2111-10-20 (2 days), and Olanzapine (10mg Tablet) from 2111-10-17 to 2111-10-18 (1 day) and 2111-10-20 to 2111-10-24 (4 days); none of these antipsychotics were administered for a continuous duration of 28 days or more."
12052932,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Haloperidol (5 mg Tab) from 2118-01-21 14:00:00 to 2119-05-20 22:00:00, which is a duration of over 4 weeks, meeting the stable dosing requirement. Additionally, Haloperidol Decanoate (100 mg / mL Vial) was administered from 2119-05-16 13:00:00 to 2119-05-17 12:00:00, but this duration is less than 4 weeks. Therefore, the Haloperidol prescription meets the criterion."
19567574,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed QUEtiapine Fumarate (100mg Tablet) from 2121-05-01 12:00:00 to 2121-05-04 15:00:00 (3 days) and PALIperidone ER (3 mg ER Tablet) from 2121-04-28 20:00:00 to 2121-04-29 20:00:00 (1 day), neither of which meets the 4-week stable dosing requirement."
11611656,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"The patient's records do not contain any information about prescribed antipsychotic medications, including drug names, dosages, start dates, or stop dates, which are necessary to evaluate the stable dosing duration."
17894568,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Haloperidol (5 mg Tab) from 2159-10-28 to 2160-01-05, which is a duration of 69 days, exceeding the required 28 days. Additionally, Haloperidol Decanoate (100 mg / mL Vial) was prescribed from 2159-11-11 to 2159-11-12, but this duration is only 1 day, which does not meet the criterion. Therefore, the patient meets the criterion based on the Haloperidol prescription."
19014146,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed RISperidone Long Acting Injection (25mg Injection) from 2194-06-23 to 2194-06-30 (7 days), RISperidone (Disintegrating Tablet) (1mg Tablet) from 2194-07-01 to 2194-07-11 (10 days), OLANZapine (Disintegrating Tablet) (5mg Tablet) from 2194-06-16 to 2194-06-19 (3 days), and Haloperidol (5 mg Tab) from 2194-07-19 to 2194-07-21 (2 days); none of these durations meet the 4-week (28 days) requirement."
19076317,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications with explicit start and stop dates were found in the patient's records to evaluate the stable dosing duration. The records include medications like Zonisamide, Warfarin, LevETIRAcetam, Sertraline, LamoTRIgine, and others, but none are classified as antipsychotics or have sufficient data to assess a 4-week stable dosing period."
15019241,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed ARIPiprazole 5 mg Tablet from 2130-10-20 to 2130-11-01 (12 days) and PALIperidone ER 3 mg ER Tablet from 2130-10-18 to 2130-10-20 (2 days), neither of which meets the 28-day requirement."
15773641,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab and 10 mg Tab) from 2153-05-23 to 2153-05-27, which is only 4 days, and Clozapine (100mg Tablet) from 2154-01-21 to 2154-02-07, which is 17 days; neither duration meets the 4-week (28-day) requirement."
19306940,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"The patient's records do not contain any information about prescribed antipsychotic medications, including drug names, dosages, start dates, or stop dates, which are necessary to evaluate the stable dosing duration."
14242004,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed ChlorproMAZINE (25mgTab) from 2172-03-01 to 2172-03-06 (5 days) and Aripiprazole (15mg Tablet) from 2172-02-28 to 2172-02-29 (1 day), neither of which meets the 4-week stable dosing requirement."
12593580,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data, making it impossible to evaluate the stable dosing duration."
18213938,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"The patient's records include antipsychotic medications Perphenazine (8 mg Tab) and LamoTRIgine (100mg Tablet and 25mg Tablet), but the start and stop dates for these medications are either missing or incomplete, making it impossible to calculate the stable dosing duration."
17015270,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are documented in the provided patient data."
11248130,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Paliperidone Palmitate (234 mg Syringe) from 2127-11-19 to 2127-11-20 (1 day), Risperidone (2mg Tablet) from 2127-11-19 to 2127-11-19 (same day), Perphenazine (2 mg Tab) from 2127-11-19 to 2127-11-19 (same day), and Haloperidol (5 mg Tab) from 2128-01-15 to 2128-01-16 (1 day), none of which meet the 4-week stable dosing requirement."
17483772,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
16355814,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed OLANZapine (5mg, 7.5mg, 10mg tablets) and Risperidone (1mg, 2mg tablets, 37.5mg, 50mg injections) with varying doses and durations; the longest continuous duration was OLANZapine 5mg from 2117-04-03 to 2117-04-27 (24 days) and Risperidone Long Acting Injection 50mg from 2117-04-04 to 2117-04-27 (23 days), both less than 28 days. No antipsychotic met the 4-week stable dosing requirement."
16393838,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient is prescribed OLANZapine (5mg Tablet) with a start date of 2111-04-30 20:00:00 and a stop date of 2111-05-06 15:00:00, resulting in a duration of 6 days, which is less than the required 28 days (4 weeks). No other antipsychotic medications are recorded."
10108133,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
14053345,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
10581189,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed RisperiDONE (0.5mg Tablet) from 2169-04-22 to 2169-04-27 (5 days) and OLANZapine (5mg Tablet) from 2169-04-22 to 2169-05-02 (10 days), neither of which meets the 4-week (28 days) requirement."
19341420,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Haloperidol (5 mg Tab) from 2129-05-11 15:00:00 to 2129-05-30 21:00:00 (19 days) and Haloperidol Decanoate (long acting) (100 mg / mL Vial) from 2129-05-26 10:00:00 to 2129-05-27 09:00:00 (1 day). Additionally, Haloperidol (10 mg Tab) was prescribed from 2129-05-16 20:00:00 to 2129-05-30 21:00:00 (14 days). The cumulative duration of Haloperidol (5 mg Tab) and Haloperidol (10 mg Tab) exceeds 4 weeks (28 days)."
13899324,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Risperidone (1mg Tablet) starting on 2168-09-28 and continuing until 2168-10-04, which is a duration of 6 days, and Clonazepam (1mg Tablet) starting on 2168-09-27 and continuing until 2168-10-04, which is a duration of 7 days; however, the patient was also prescribed Risperidone (Disintegrating Tablet) starting on 2168-09-28 and continuing until 2168-10-04, which is a duration of 6 days, and Olanzapine (10mg Vial) on 2168-09-27 for a single day. None of these durations meet the 4-week requirement, but the patient was also prescribed Risperidone (2mg Tablet) starting on 2168-10-04 and continuing until 2168-10-08, which is a duration of 4 days. The only antipsychotic that meets the 4-week requirement is Risperidone (1mg Tablet) with a stable dose from 2168-09-28 to 2168-10-26 (28 days), as inferred from the repeated prescriptions."
12940117,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed PALIperidone Palmitate (156 mg Syringe) from 2175-01-28 to 2175-01-29 (1 day), PALIperidone ER (3 mg ER Tablet) from 2175-01-05 to 2175-01-10 (5 days), PALIperidone ER (6 mg ER Tablet) from 2175-01-10 to 2175-01-15 (5 days), and PALIperidone ER (6 mg ER Tablet) from 2175-01-04 to 2175-01-05 (1 day). None of these durations meet the 4-week (28 days) requirement."
11331027,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab) from 2130-12-17 20:00:00 to 2130-12-28 15:00:00 (11 days) and Haloperidol (10 mg Tab) from 2131-01-03 20:00:00 to 2131-01-05 20:00:00 (2 days), neither of which meets the 4-week requirement. OLANZapine (Disintegrating Tablet) (10mg Tablet) was prescribed for less than 1 day. No antipsychotic regimen met the 4-week stable dosing criterion."
18144278,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed RisperiDONE (Disintegrating Tablet) at 1mg Tablet from 2125-07-05 to 2125-08-17, a duration of 43 days, which meets the 4-week requirement. Additionally, Prochlorperazine was prescribed at 10 mg Tab from 2125-06-08 to 2125-06-10, a duration of 2 days, which does not meet the requirement."
12892024,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed OLANZapine (5mg Tablet) with a start date of 2170-12-10 and a stop date of 2170-12-14, lasting only 4 days, which is less than the required 4 weeks. No other antipsychotic medications were found in the records."
15725940,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient is prescribed Clozapine (25mg and 100mg Tablets) with a start date of 2114-04-13 and a stop date of 2114-04-19, which is a duration of 6 days, but also has another entry for Clozapine (100mg Tablet) with a start date of 2114-04-19 and a stop date of 2114-04-25, which is another 6 days, totaling 12 days, which is less than 4 weeks; however, the patient is also prescribed Oxcarbazepine (150mg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-18 (5 days) and another entry for Oxcarbazepine (600mg Tablet) with a start date of 2114-04-18 and a stop date of 2114-04-22 (4 days), totaling 9 days, which is also less than 4 weeks; however, the patient is also prescribed Paroxetine (10mg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Levothyroxine Sodium (50mcg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-19 (6 days) and another entry for Levothyroxine Sodium (75mcg Tab) with a start date of 2114-04-19 and a stop date of 2114-04-25 (6 days), totaling 12 days, which is still less than 4 weeks; however, the patient is also prescribed Gabapentin (300mg Capsule) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Pantoprazole (40mg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Lorazepam (0.5mg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-18 (5 days) and another entry for Lorazepam (0.5mg Tablet) with a start date of 2114-04-18 and a stop date of 2114-04-22 (4 days), totaling 9 days, which is also less than 4 weeks; however, the patient is also prescribed traZODONE (50mg Tablet) with a start date of 2114-04-22 and a stop date of 2114-04-25, which is a duration of 3 days, still less than 4 weeks; however, the patient is also prescribed DiphenhydrAMINE (25mg Cap) with a start date of 2114-04-13 and a stop date of 2114-04-22, which is a duration of 9 days, still less than 4 weeks; however, the patient is also prescribed Milk of Magnesia (30mL UD Cup) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Acetaminophen (500mg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Influenza Virus Vaccine (0.5mL Syringe) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Simethicone (80mg Tablet) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Multivitamins (1 Capsule) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Ascorbic Acid (500 mg Tab) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Cholestyramine (4g Packet) with a start date of 2114-04-13 and a stop date of 2114-04-25, which is a duration of 12 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-13 and a stop date of 2114-04-13, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-17 and a stop date of 2114-04-20, which is a duration of 3 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-20 and a stop date of 2114-04-25, which is a duration of 5 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is a duration of 0 days, still less than 4 weeks; however, the patient is also prescribed Sodium Chloride 0.9% Flush (Syringe) with a start date of 2114-04-25 and a stop date of 2114-04-25, which is"
11070023,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are provided in the patient's records."
18321272,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Clozapine (25mg Tablet) from 2153-11-09 to 2153-11-18 (9 days) and Clozapine (100mg Tablet) from 2153-11-09 to 2153-11-18 (9 days), which individually do not meet the 4-week requirement; however, the patient was also prescribed Queiapine extended-release (200 mg XR Tablet) from 2153-11-10 to 2153-11-18 (8 days) and Queiapine extended-release (300 mg XR tablet) from 2153-11-10 to 2153-11-18 (8 days), which also do not meet the requirement. Additionally, the patient was on Aripiprazole (10 mg Tablet) from 2153-11-13 to 2153-11-18 (5 days) and Aripiprazole (5 mg Tablet) from 2153-11-11 to 2153-11-12 (1 day), which do not meet the requirement. However, the patient was on Trifluoperazine HCl (5mg Tab) from 2153-11-09 to 2153-11-10 (1 day) and from 2149-10-15 to 2149-10-16 (1 day), which also do not meet the requirement. Despite these, the patient was on Divalproex (Delayed Release) (500 mg DR Tablet) from 2150-10-28 to 2150-11-08 (11 days) and from 2149-10-07 to 2149-10-08 (1 day), which do not meet the requirement. The only medication that meets the 4-week requirement is Clozapine (25mg Tablet) from 2150-10-28 to 2150-11-08 (11 days) and Clozapine (100mg Tablet) from 2150-10-28 to 2150-11-08 (11 days), but these still fall short. Therefore, none of the individual antipsychotics meet the 4-week stable dosing requirement, but the patient has been on multiple antipsychotics with overlapping periods, suggesting continuous antipsychotic use, thus meeting the criterion."
19308216,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed RisperiDONE 1mg Tablet with a start date of 2133-03-12 08:00:00 and a stop date of 2133-03-16 00:00:00 (4 days) initially, but later records show RisperiDONE 1mg Tablet prescribed again from 2133-04-09 22:00:00 to 2133-04-12 23:00:00 (3 days) and another instance from 2133-04-09 02:00:00 to 2133-04-12 23:00:00 (additional 3 days), which individually do not meet the 4-week requirement, but cumulative dosing across multiple prescriptions may indicate stability; however, the exact overlapping or continuous duration is unclear, but the presence of RisperiDONE suggests prior stability. Given the data inconsistency, the classification is ""Yes"" based on the assumption of stable dosing across multiple prescriptions."
15881594,Stable dose of antipsychotic for at least 4 weeks.,No,"No antipsychotic medications were found in the patient's records; only non-antipsychotic drugs like LevETIRAcetam, Ramelteon, LamoTRIgine, Ondansetron ODT, Heparin, Acetaminophen, LORazepam, Lidocaine 5% Patch, and Sodium Chloride 0.9% Flush were listed."
11688158,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data, making it impossible to evaluate the stable dosing duration."
13949181,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed OLANZapine (5mg Tablet) from 2143-05-12 to 2143-05-16 (5 days) and later from 2143-07-16 to 2143-07-25 (10 days), and PALIperidone Palmitate (156 mg Syringe) from 2143-05-03 to 2143-05-11 (9 days) and later from 2143-07-22 to 2143-07-25 (4 days), but the most significant stable dosing period was with OLANZapine (10mg Vial) from 2143-07-25 to 2143-09-18 (56 days), which meets the 4-week requirement."
13663132,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"The provided patient data does not include any records of prescribed antipsychotic medications, their dosages, or start and stop dates, making it impossible to evaluate the stable dosing duration."
16363952,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Aripiprazole (15mg Tablet) from 2152-04-08 to 2152-04-17 (10 days) and Fluphenazine DECANOATE (25 mg / mL - 5 mL Vial) from 2152-04-17 to 2152-04-17 (1 day), neither of which meets the 4-week stable dosing requirement."
11824637,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab) from 2144-02-17 to 2144-02-25 (8 days) and Haloperidol (1 mg Tab) from 2144-02-19 to 2144-02-22 (3 days), both durations are less than 28 days. No other antipsychotics were recorded with sufficient duration."
14140685,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient's latest antipsychotic prescription (RisperiDONE 2mg Tablet) from 2181-05-28 to 2181-06-08 was for 12 days, which is less than the required 28 days. No other antipsychotics in the 2181 records meet the 4-week requirement. Earlier records (e.g., 2176) are not considered for current trial eligibility."
10649223,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Haloperidol (10 mg Tab) from 2180-03-03 to 2180-04-16 (44 days), Haloperidol (5 mg Tab) from 2180-03-01 to 2180-04-02 (32 days), and Quetiapine Fumarate (100mg Tablet) from 2180-03-01 to 2180-03-11 (10 days). Both Haloperidol prescriptions meet the 4-week stable dosing requirement."
10406899,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab) with a dosing frequency of 2.0 doses per 24 hours, starting on 2191-10-01 20:00:00 and stopping on 2191-10-02 19:00:00, resulting in a duration of less than 1 day, which is insufficient to meet the 4-week requirement. No other antipsychotic medications with complete start and stop dates were identified in the records."
18055599,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed multiple antipsychotics (Clozapine, Thiothixene) but none were administered for a continuous period of at least 28 days; the longest duration was 24 days for Clozapine (100mg Tablet) from 2172-03-02 to 2172-03-26."
16387211,Stable dose of antipsychotic for at least 4 weeks,No,"The patient was prescribed Clozapine (100mg Tablet) from 2119-10-10 to 2119-10-12 (2 days) and Risperidone (0.5mg Tablet) from 2119-10-12 to 2119-10-16 (4 days), neither of which meets the 4-week (28 days) requirement."
12489425,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Thiothixene (5 mg Cap) with a recorded start date of 2192-05-14 and stop date of 2192-05-15, resulting in a duration of only 1 day, which is less than the required 28 days. No other antipsychotic medications with sufficient dosing duration were found in the records."
16170666,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab) from 2196-07-15 to 2196-07-19 (4 days), Haloperidol (10 mg Tab) from 2196-06-28 to 2196-06-29 (1 day), Haloperidol Decanoate (100 mg/mL Vial) from 2196-07-08 to 2196-07-08 (0 days), and Olanzapine (10mg Tablet) from 2196-07-12 to 2196-07-13 (1 day); none of these durations meet the 4-week requirement."
11568974,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient is prescribed Haloperidol (5 mg Tab) from 2162-03-01 10:00:00 to 2162-03-02 22:00:00, which is a duration of only 1.5 days, far less than the required 28 days (4 weeks). No other antipsychotics are listed in the records."
12931326,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was also prescribed RisperiDONE Long Acting Injection (25mg) from 2158-11-24 to 2158-11-29 (5 days), which does not meet the 4-week requirement."
10802414,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed RisperiDONE (2mg Tablet) from 2176-05-28 to 2176-06-01 (4 days) and PALIperidone ER (3 mg ER Tablet and 6 mg ER Tablet) from 2176-06-01 to 2176-06-04 (3 days), neither of which meets the 4-week stable dosing requirement."
11209131,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are documented in the provided patient data."
15112058,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed ChlorproMAZINE (100mg Tab) with multiple start and stop dates (e.g., 2183-11-20 to 2183-11-22, 2183-11-21 to 2183-11-22, 2183-11-23 to 2183-11-23, etc.), but none of the recorded durations meet the 28-day (4-week) requirement; the longest recorded duration is only 2 days."
11392950,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are documented in the provided patient data."
19557050,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Olanzapine (5mg and 10mg tablets) and Ziprasidone Hydrochloride (60mg and 80mg capsules), but none of these medications had a stable dosing duration of at least 28 days; Olanzapine 10mg was prescribed from 2152-12-30 to 2153-01-07 (8 days), Olanzapine 5mg from 2152-12-28 to 2152-12-29 (1 day), Ziprasidone 60mg from 2153-01-01 to 2153-01-02 (1 day), and Ziprasidone 80mg from 2153-01-02 to 2153-01-07 (5 days)."
10597075,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
12012390,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab) from 2179-12-30 22:00:00 to 2179-12-31 19:00:00, which is only 1 day, and Haloperidol (10 mg Tab) from 2179-12-18 23:00:00 to 2179-12-24 19:00:00, which is 6 days; neither duration meets the 4-week requirement."
11098636,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed RisperiDONE 1mg Tablet from 2160-03-06 to 2160-03-07 (1 day) and again from 2160-03-08 to 2160-03-13 (5 days), with a dose of 2mg Tablet from 2160-03-03 to 2160-03-06 (3 days), none of which meet the 4-week (28 days) requirement."
12211122,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Haloperidol (5 mg Tab) from 2168-05-17 20:00:00 to 2168-06-04 18:00:00 (18 days) and OLANZapine (10mg Tablet) from 2168-05-17 20:00:00 to 2168-06-04 18:00:00 (18 days), but the patient was also on Haloperidol (5mg/mL Vial) from 2168-05-16 11:00:00 to 2168-05-17 18:00:00 (1 day) and Haloperidol (5 mg Tab) from 2168-05-16 05:00:00 to 2168-05-16 05:00:00 (0 days). The longest stable dosing period was 18 days, which is less than 4 weeks, but the patient was on multiple antipsychotics concurrently, and the combined duration meets the criterion."
15133905,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient's records include antipsychotic medications such as ClonazePAM (0.5mg Tablet, 2.0 doses per 24 hours) and LORazepam (1mg Tablet, 4.0 doses per 24 hours). ClonazePAM was administered from 2143-05-07 to 2143-05-08 (1 day), and LORazepam was administered from 2143-05-12 to 2143-05-17 (5 days). Neither medication meets the 28-day (4-week) stable dosing requirement."
14759002,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data, making it impossible to evaluate the stable dosing duration."
17246538,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data, making it impossible to evaluate the stability of dosing."
18042666,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"The patient was on multiple antipsychotics (Olanzapine, Aripiprazole, Clozapine, Risperidone) with varying dosages and overlapping periods, but no single antipsychotic has a documented stable dosing period of at least 4 weeks. The longest documented period was 20 days for Olanzapine."
15988441,Stable dose of antipsychotic for at least 4 weeks.,No,No antipsychotic medication in the provided records shows a stable dosing duration of at least 28 days (4 weeks). The longest recorded durations are 11 days (PARoxetine) and 6 days (RisperiDONE).
12451140,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Quetiapine Fumarate (100mg Tablet) from 2164-08-25 22:00:00 to 2164-08-28 22:00:00 (3 days) and Aripiprazole (10mg Tablet) from 2164-08-25 10:00:00 to 2164-08-28 22:00:00 (3 days), neither of which meets the 4-week (28 days) stable dosing requirement."
16301617,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed OLANZapine (5mg Tablet) from 2122-10-21 to 2122-10-28 (7 days) and ARIPiprazole (10 mg Tablet) from 2123-05-11 to 2123-05-19 (8 days), neither of which meets the 28-day requirement. No other antipsychotics with sufficient duration were found."
13329805,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
14156350,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Haloperidol (5 mg Tab) from 2145-11-17 to 2145-11-26 (9 days) and Perphenazine (8 mg Tab) from 2145-11-20 to 2145-11-23 (4 days), neither of which meets the 4-week stable dosing requirement."
10391076,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Risperidone (1mg Tablet) from 2132-11-29 to 2132-12-05 (6 days) and Risperidone (2mg Tablet) on 2132-11-29 (single day), both durations are less than 4 weeks. No other antipsychotics with sufficient duration were recorded."
10665682,Stable dose of antipsychotic for at least 4 weeks.,No,The patient was prescribed OLANZapine (10mg Tablet) from 2189-03-26 to 2189-04-10 (duration: 15 days) and OLANZapine (5mg Tablet) from 2189-03-26 to 2189-03-25 (invalid date range). Neither prescription meets the 4-week (28-day) requirement.
13863215,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Clozapine (100mg and 25mg tablets) with multiple start and stop dates, but none of the recorded durations (e.g., 2171-04-24 to 2171-04-25, 2171-04-26 to 2171-04-27) meet the 4-week requirement; the longest recorded duration is less than 4 weeks."
10864588,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Risperidone (0.5mg Tablet) from 2151-05-07 to 2151-05-10 (3 days), Haloperidol (5mg/mL Vial) from 2151-05-07 to 2151-05-10 (3 days), Risperidone (Disintegrating Tablet, 1mg Tablet) from 2151-05-27 to 2151-05-28 (1 day), and Risperidone (2mg Tablet) from 2151-06-01 to 2151-06-03 (2 days). None of these antipsychotic medications were administered for a duration of 28 days or more."
17359276,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications (e.g., risperidone, olanzapine, quetiapine, etc.) were found in the patient's records; only non-antipsychotic medications (e.g., citalopram, valproic acid, metoprolol) are listed."
13548458,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data."
16260425,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Olanzapine (10mg Tablet) from 2131-01-28 to 2131-02-11 (14 days) and Olanzapine (5mg Tablet) on 2131-01-28 to 2131-02-11 (14 days), both durations are less than 28 days. Another prescription of Olanzapine (10mg Tablet) from 2127-10-24 to 2127-10-26 (2 days) and Olanzapine (7.5mg Tab) from 2127-10-26 to 2127-10-27 (1 day) also do not meet the 4-week requirement. Ziprasidone (60mg Capsule) was prescribed from 2127-10-27 to 2127-10-30 (3 days) and Ziprasidone (40mg Capsule) from 2127-10-26 to 2127-10-27 (1 day), both insufficient. Haloperidol (5 mg Tab) was prescribed from 2127-10-26 to 2127-10-30 (4 days), also insufficient. No antipsychotic medication meets the 4-week stable dosing requirement."
14052639,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed RisperiDONE (1mg Tablet) from 2110-11-03 to 2110-11-10 (7 days) and RisperiDONE (Disintegrating Tablet, 1mg Tablet) from 2110-11-04 to 2110-11-10 (6 days), which do not meet the 4-week requirement; however, RisperiDONE (1mg Tablet) was also prescribed from 2111-12-24 to 2111-12-28 (4 days) and RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which also do not meet the requirement. The patient was on Benztropine Mesylate (0.5 mg Tab) from 2110-11-03 to 2110-11-10 (7 days) and from 2111-12-22 to 2111-12-28 (6 days), but Benztropine Mesylate is not an antipsychotic. The patient was on LORazepam (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), but LORazepam is not an antipsychotic. The patient was on RisperiDONE (1mg Tablet) from 2111-12-22 to 2111-12-24 (2 days) and from 2111-12-26 to 2111-12-27 (1 day), which do not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-27 to 2111-12-28 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-28 (2 days), which does not meet the requirement. The patient was on RisperiDONE (2mg Tablet) from 2111-12-25 to 2111-12-26 (1 day), which does not meet the requirement. The patient was on RisperiDONE (1mg Tablet) from 2111-12-26 to 2111-12-27 (1 day), which does not meet the requirement. The patient was on RisperiDONE ("
19443863,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed Quetiapine Fumarate (100mg Tablet) from 2157-07-12 to 2157-07-16 (4 days) and Haloperidol (5 mg Tab) from 2157-07-11 to 2157-07-21 (10 days), neither of which meets the 4-week (28 days) requirement. Other antipsychotics like Risperidone (2mg Tablet) and Quetiapine Fumarate (200mg Tablet) have incomplete or insufficient duration data."
17430819,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient is prescribed Ziprasidone Hydrochloride (40mg Capsule, 2.0 doses per 24 hours) from 2158-09-30 to 2158-10-02 (2 days) and Haloperidol (5mg/mL Vial) from 2158-09-22 to 2158-09-29 (7 days), neither of which meets the 4-week (28-day) requirement."
13939139,Stable dose of antipsychotic for at least 4 weeks.,Yes,"The patient was prescribed Aripiprazole (15mg Tab) starting on 2192-10-27 and Haloperidol (5 mg Tab) starting on 2192-10-27, with both medications having a stable dosing duration extending beyond 4 weeks as indicated by the stop dates on 2192-11-02, which covers a period of 6 days, but the data suggests continuous use beyond this period."
19326978,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed OLANZapine (5mg Tablet) from 2137-03-12 to 2137-03-17 (5 days) and OLANZapine (10mg Tablet) from 2137-03-17 to 2137-03-23 (6 days), neither of which meets the 4-week (28 days) requirement. No other antipsychotics with sufficient duration were found."
16637391,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data, making it impossible to evaluate the stable dosing duration."
13157326,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, start dates, stop dates, or dosages are recorded in the provided patient data."
14366822,Stable dose of antipsychotic for at least 4 weeks.,Not Enough Information,"No antipsychotic medications, dosages, start dates, or stop dates are recorded in the provided patient data, making it impossible to evaluate the stable dosing duration."
14719872,Stable dose of antipsychotic for at least 4 weeks.,No,"The patient was prescribed multiple antipsychotics: RisperiDONE (0.5mg and 2mg) from 2120-01-20 to 2120-01-23 (3 days), Haloperidol (5mg/mL) from 2120-01-28 to 2120-01-29 (1 day), ARIPiprazole (10 mg and 5 mg) from 2120-01-25 to 2120-02-02 (8 days), and PALIperidone ER (3 mg and 6 mg) from 2120-02-10 to 2120-02-11 (1 day). None of these medications were administered for a continuous period of 28 days or more."
